Alterations of the human gut Methanobrevibacter smithii as a biomarker for inflammatory bowel diseases.

MLA

Ghavami, Shaghayegh Baradaran, et al. “Alterations of the Human Gut Methanobrevibacter Smithii as a Biomarker for Inflammatory Bowel Diseases.” Microbial Pathogenesis, vol. 117, Apr. 2018, pp. 285–89. EBSCOhost, https://doi.org/10.1016/j.micpath.2018.01.029.

APA

Ghavami, S. B., Rostami, E., Sephay, A. A., Shahrokh, S., Balaii, H., Aghdaei, H. A., & Zali, M. R. (2018). Alterations of the human gut Methanobrevibacter smithii as a biomarker for inflammatory bowel diseases. Microbial Pathogenesis, 117, 285–289. https://doi.org/10.1016/j.micpath.2018.01.029

Chicago

Ghavami, Shaghayegh Baradaran, Elham Rostami, Abbas Akhavan Sephay, Shabnam Shahrokh, Hedieh Balaii, Hamid Asadzadeh Aghdaei, and Mohammad Reza Zali. 2018. “Alterations of the Human Gut Methanobrevibacter Smithii as a Biomarker for Inflammatory Bowel Diseases.” Microbial Pathogenesis 117 (April): 285–89. doi:10.1016/j.micpath.2018.01.029.